A new lawsuit against Bayer over the birth control pill Yaz has been filed in federal court in Illinois.Read More »
Bayer could pay more than $1.2 billion to settle personal injury lawsuits over the company’s Yaz and Yasmin birth control pills, according to a recent stock filing.Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
Drospirenone-containing birth control pills like Bayer’s Yaz and Yasmin may be associated with a higher risk for blood clots than progestin-containing pills, the Food and Drug Administration has concluded.Read More »
An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel’s recommendation to keep the popular birth control drugs Yaz and Yasmin on the market, citing evidence that several panel members operated under conflicts of ...Read More »
Two federal advisory panels voted earlier this month in favor of requiring Bayer AG to update warning labels on its popular birth control drug Yaz to reflect new concerns of an increased risk of blood clots.Read More »